Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J touts Caplyta win in 1 of 2 bipolar manic episode studies
Caplyta helped deliver rapid improvement in manic symptoms and overall illness severity versus placebo in adults with bipolar-related manic episodes.
Fraiser Kansteiner
Sep 21, 2026 2:30pm
UCB’s Bimzelx claims August’s top pharma ad spending spot
Sep 4, 2026 9:18am
FDA endorses J&J’s Imaavy to treat rare anemia disorder
Aug 25, 2026 9:20am
Legend interim CEO talks transition, Carvykti challenges
Aug 12, 2026 2:44pm
AbbVie’s Skyrizi leading drug in pharma’s ad spending league
Aug 7, 2026 9:45am
J&J innovative medicine chief Jennifer Taubert to retire
Aug 4, 2026 10:55am
